News

ThreeD Capital Inc. Successfully Completes Private Placement

ThreeD Capital Inc. Successfully Completes Private Placement

ThreeD Capital Inc. Successfully Completes Private Placement

ThreeD Capital Inc. (CSE:IDK / OTCQX:IDKFF) is making waves in the investment community with the completion of its latest private placement financing. The Canadian venture capital firm, known for its opportunistic investments in junior resources and disruptive technologies, has successfully concluded the placement, bringing in total gross proceeds of $1,956,000 through the issuance of 13,040,000 units at a price of $0.15 each.

Understanding the Private Placement

The units issued during this private placement consist of one common share and one common share purchase warrant. Each warrant grants its holder the right to acquire an additional common share at an exercise price of $0.22 for up to 36 months. This strategic move allows ThreeD to strengthen its financial position and continue pursuing its investment strategy without incurring any commission or finder’s fees.

Details of the Financing Arrangement

This financing arrangement effectively expands ThreeD's capabilities in the investment landscape. All securities associated with the private placement will be subject to a hold period lasting four months plus one day, set to conclude on a future date. This ensures careful management of equity distribution while enhancing the investment appeal.

Insiders' Involvement

Interestingly, the management and directors, collectively referred to as Insiders, played a significant role by acquiring a total of 4,200,000 units. Their participation highlights confidence in ThreeD's potential. This is considered a related party transaction, governed under Multilateral Instrument 61-101, which protects minority shareholders in special transactions. By adhering to the relevant guidelines, the company is now positioned to leverage its resources effectively.

About ThreeD Capital Inc.

Founded as a publicly-traded venture capital firm, ThreeD focuses on making strategic investments in the realms of junior resources and innovative technologies. The company’s investment strategy is multifaceted, involving an approach that spans various private and public companies across different sectors on a global scale. ThreeD is especially keen on engaging with early-stage companies, positioning itself as a lead investor while providing them with advisory services and a robust ecosystem of resources.

Looking Ahead

As ThreeD Capital Inc. moves forward from this financing, it is positioned to enhance its investment activities significantly. With its strategic issuance of units, the firm is well-prepared to back promising ventures, offering financial, technical, and advisory support that could spearhead growth in the industries it operates within. This successful closing not only solidifies ThreeD's financial standing but also opens up avenues for further expansion in the innovative technology and junior resource sectors.

Director Statements

The team at ThreeD believes that their recent funding efforts will empower the firm to identify and capitalize on new opportunities in evolving markets. By focusing on industries that show sustainable growth, ThreeD aims to deliver excellent returns on investment for its stakeholders, creating a roadmap for future financial success.

Frequently Asked Questions

What is a private placement?

A private placement is a way for companies to raise capital by selling securities directly to a small group of investors, rather than through public offerings.

How does ThreeD Capital invest?

ThreeD Capital invests in both private and public companies focusing on sectors such as junior resources and disruptive technologies.

What does it mean for insiders to participate in a private placement?

Insider participation indicates confidence in the company’s potential growth and can create added trust among other investors.

What are common share purchase warrants?

These are financial instruments that give the holder the right to purchase a company’s common shares at a pre-determined price for a specific period.

How can I contact ThreeD Capital Inc.?

Matthew Davis, CPA, Chief Financial Officer, can be reached via phone at 416-941-8900 for more information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 166

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 174

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 365

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 108

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 227

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 153

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 211

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 182

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading

Top 5 Most Recently Viewed Articles

BlueLinx Expands Its Reach with New Portland Distribution Hub

Updated Category News Views 147

BlueLinx Unveils New Distribution Center in Portland BlueLinx Holdings Inc. (NYSE: BXC) has officially opened a greenfield distribution center in Portland, enhancing its operational footprint in the Pacific Northwest. This facility is a significant addition to the company’s distribution capabilities, as it strategically positions BlueLinx to serve the growing demands of...

Continue Reading
IBA Partners with China Gold to Advance X-ray Technological Growth

Updated Category News Views 255

Strategic Partnership for Industry Advancement In a significant move for the irradiation processing industry, IBA (Ion Beam Applications S.A., EURONEXT) has joined forces with China Gold Irradiation (CGI), the premier irradiation service provider in China. This collaboration is set to elevate the standards of irradiation services by incorporating advanced X-ray...

Continue Reading
Amerant Bank and Partners Generate Support for Local Charity

Updated Category News Views 189

Generous Collaboration: Amerant Bank's Community Impact In a heartwarming display of community spirit, Amerant Bank has partnered with Sedano’s Supermarkets and Fresco y Más to make a significant difference in the lives of underserved children and families. The culmination of their efforts was marked by a grand check presentation to Centro Mater, a renowned...

Continue Reading
Mediar Therapeutics Advances Phase 2 Trial for Rare Lung Disease

Updated Category News Views 123

Mediar Therapeutics Initiates Phase 2 WISPer Trial Mediar Therapeutics, Inc., a pioneering clinical-stage biotechnology company, has reached a major milestone by dosing the first patient in its Phase 2 WISPer clinical trial. This trial focuses on evaluating MTX-463, a first-in-class therapy designed to combat idiopathic pulmonary fibrosis (IPF). The primary goal of this...

Continue Reading
Chime Biologics and Waterstone Unite for ADC Innovation

Updated Category News Views 242

Chime Biologics and Waterstone Forge a New Path in ADC Development Chime Biologics and Waterstone Pharmaceuticals have officially announced a strategic partnership designed to enhance the capabilities and efficiencies within the Antibody-Drug Conjugate (ADC) industry. By combining their expertise, both companies aim to provide integrated services that boost the...

Continue Reading